Upgrade to SI Premium - Free Trial

TherapeuticsMD (TXMD) Tops Q3 EPS by 6c

November 6, 2019 4:52 PM
TherapeuticsMD (NASDAQ: TXMD) reported Q3 EPS of ($0.13), $0.06 better than the analyst estimate of ($0.19). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Management Comments

Next Articles